Physician profile
Martin E Orlick
NPI 1003816018
$2,312.14
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $543 · 2020: $44.06 · 2021: $452 · 2022: $437 · 2023: $535 · 2024: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $798 · Education: $38.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.06 |
| Education | $38.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $404.18 | 2022-2024 | Acthar |
| Genentech USA, INC. | $347.36 | 2019-2023 | Vabysmo, Lucentis |
| Notal Vision, INC. | $291.79 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $227.15 | 2019-2024 | Eylea, Eylea Hd |
| Shire North American Group INC | $212.50 | 2019 | |
| Allergan, INC. | $192.64 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $130.65 | 2019-2021 | |
| Astellas Pharma US INC | $106.18 | 2023-2024 | Izervay |
| Ani Pharmaceuticals, INC. | $92.59 | 2023 | Purified Cortrophin Gel |
| Biogen, INC. | $65.47 | 2022-2023 | |
| Abbvie INC. | $57.02 | 2022-2023 | |
| Apellis Pharmaceuticals, INC. | $46.80 | 2022-2024 | Syfovre |
| Alimera Sciences, INC. | $41.58 | 2019 | |
| Bausch & Lomb Americas INC. | $35.98 | 2024 | Xipere, Miebo |
| Alcon Vision LLC | $23.36 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $20.21 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Orlick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.